Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.75 | 0.002 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.58 | 0.05 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.37 | 0.4 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.19 | 0.1 |